Modulation of myeloid cells may be superior to other strategies in clinical development aimed at depleting myeloid cells since the early modulation of myeloid cells preceded the sustained infiltration of CD8+ and CD4+ T lymphocytes, which was essential for anti-tumour efficacy. The gene discussed is CD8A; the disease is neoplasm.